Loading news...
AXIS Capital Holdings Limited is downgraded to 'Hold' after a strong multi-year run and recent volatility. AXS's profitability faces headwinds from unfavorable pricing trends, increased MGA competition, and muted near-term growth expectations. Technical signals indicate a potential topping pattern, with broken trendlines and bearish momentum on both short- and long-term charts.
AXSM doses the first patient in the phase III FORWARD study testing AXS-14 for fibromyalgia.
CNBC's Contessa Brewer interviews Axis Capital CEO Vince Tizzio about insights from company's AI and Cyber Readiness study.
Stewart Information Services (NYSE: STC - Get Free Report) and Axis Capital (NYSE: AXS - Get Free Report) are both finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, dividends, risk, institutional ownership, analyst recommendations, earnings and profitability. Dividends Stewart Information Services pays an annual
Clear Harbor Asset Management LLC trimmed its holdings in Axis Capital Holdings Limited (NYSE: AXS) by 21.0% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 58,833 shares of the insurance provider's stock after selling 15,654 shares during
PEMBROKE, Bermuda, Jan. 08, 2026 (GLOBE NEWSWIRE) -- AXIS Capital Holdings Limited (“AXIS Capital” or the “Company”) (NYSE: AXS) today announced that it expects to release financial results for the fourth quarter ended December 31, 2025 on Wednesday, January 28, 2026 after the close of the financial markets.
AXS trades above key SMAs as its specialty lines strategy drives gains, but muted earnings outlook tempers the case.
New Drug Application (NDA) submission on track for January 2026 NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it has received formal pre-New Drug Application (NDA) meeting minutes from the U.S. Food and Drug Administration (FDA) supporting an NDA submission for AXS-12 in narcolepsy. AXS-12 (reboxetine) is a highly selective and potent norepinephrine reuptake inhibitor and cortical dopamine modulator.
Permanent Capital Management LP bought a new stake in shares of Axis Capital Holdings Limited (NYSE: AXS) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 12,355 shares of the insurance provider's stock, valued at approximately $1,189,000. Other hedge funds
Investors with an interest in Insurance - Property and Casualty stocks have likely encountered both Axis Capital (AXS) and Kinsale Capital Group, Inc. (KNSL). But which of these two companies is the best option for those looking for undervalued stocks?
Axis Capital Holdings Limited (NYSE: AXS - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the eleven analysts that are covering the firm, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation, seven have given a buy recommendation and one has assigned a strong buy recommendation to the
TRV, AXS, JXN, LNC and GL have outperformed in 2025 and look set to deliver strong returns in 2026 too.
Does Axis Capital (AXS) have what it takes to be a top stock pick for momentum investors? Let's find out.
PEMBROKE, Bermuda--(BUSINESS WIRE)---- $AXS #insurance--AXIS Capital Holdings Limited ("AXIS Capital" or the “Company”) (NYSE: AXS) today announced that its Board of Directors has declared a quarterly dividend of $0.44 per common share payable on January 15, 2026 to shareholders of record at the close of business on December 31, 2025. In addition, the Board declared a dividend of $34.375 per Series E 5.50% preferred share (equivalent to $0.34375 per depositary share) payable on January 15, 2026 to shareholders of.
AXIS Capital gains from a well-performing specialty insurance, reinsurance, and the accident and health portfolio.
Investors interested in stocks from the Insurance - Property and Casualty sector have probably already heard of Axis Capital (AXS) and Cincinnati Financial (CINF). But which of these two stocks offers value investors a better bang for their buck right now?
For 3Q25, the Macquarie Small Cap Value Fund Institutional class shares lagged the stronger return of its benchmark, the Russell 2000 Value Index. Stock selection and an underweight allocation detracted in the healthcare sector. Stock selection in technology detracted as the Fund's positions in the semiconductors and semiconductor equipment industries underperformed.
Axis Capital (AXS) reported earnings 30 days ago. What's next for the stock?
Discover five low P/B picks like STNE that are undervalued and show solid growth potential based on value-focused filters.
Axis Capital Holdings Limited (NYSE: AXS - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the ten analysts that are currently covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1-year target